News & Perspective

Oct 19, 2017

Oct 19, 2017
Ferret

Study details pandemic potential of latest H7N9 flu strains

In a sample from a patient who died, researchers saw signs that the H7N9 virus had started to mutate to a form resistant to Tamiflu.

Jul 07, 2017

Jul 07, 2017
Smallpox

Canadian group creates poxvirus, prompting dual-use discussion

Though the technology isn't likely within reach of do-it-yourselfers, it could already be in use by rogue governments, experts say.

Jun 01, 2016

Jun 01, 2016
Biosafety PPE

NSABB finalizes GOF guidance; White House to weigh in

The group voted unanimously on policy regarding avian flu and other viruses.

Mar 08, 2016

Mar 08, 2016
Influenza researcher

COMMENTARY: Six policy options for conducting gain-of-function research

Experts offer approaches for moving the GOF conundrum forward that are not mutually exclusive, such as lifting the moratorium, seeking international consensus, and establishing a review board.

Jan 08, 2016

Jan 08, 2016
BSL4

Gain-of-function debate focuses on clarity, global perspective

The next step in the deliberations is a 2-day National Academies of Science symposium in March. 

Jan 07, 2016

Jan 07, 2016
Mutated virus

NSABB launches new phase of GOF research debate

Some topics: weighing risks and benefits, ethical issues, and global involvement.

Dec 11, 2015

Dec 11, 2015
Lab vials and syringes

GOF risk-benefit analysis unveiled ahead of NSABB debate

The analysis is a key part of a federal review of controversial studies on H5N1 and other pathogens.

Oct 02, 2015

Oct 02, 2015
Culturing cells in petri dish

Work continues on policies for 'gain of function' research

The NSABB plans to release final recommendations in spring 2016.

Jul 17, 2015

Jul 17, 2015
BSL-3 lab

Feds propose adding H5N1 to HHS select agent list

The CDC proposes adding certain H5N1 viruses to HHS's select agent list; experts have varied reactions.

Jun 17, 2015

Jun 17, 2015
Clostridium botulinum colony

Study: Novel botulinum toxin less dangerous than thought

A new botulinum toxin can be blocked using available antitoxins, a new study says.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»